Gadolinium retention has not been directly linked to adverse health effects in patients with normal kidney function, and we have concluded that the benefit of all approved GBCAs continues to...

2024年10月10日 · Nephrologists identified gadolinium as the most significant risk factor in 2006. Gadolinium was detected in skin biopsies of people with this condition. By 2007, the FDA …

Four conditions have been described by researchers and clinicians as due to the long-term retention and accumulation of gadolinium in a patient’s body. The most well-known and …

2024年9月26日 · The most common gadolinium side effects are injection site pain, itching and nausea. These are typically mild. These contrasting agents carry a boxed warning for …

2023年10月18日 · Although extraordinarily safe, gadolinium-based contrast agents (GBCAs) may have side effects. Four distinct safety considerations include acute allergiclike reactions, …

Gadolinium contrast agents help improve the quality of MRI scans. Side effects include nephrogenic systemic fibrosis (NSF) which is associated with the administration of intravenous …

Health care professionals should consider the retention characteristics of each agent when choosing a GBCA for patients who may be at higher risk for gadolinium retention, including …

Gadolinium-based contrast agents are rare earth metals that are usually given through an IV in the arm. For more information about MRI and their safety and risks, please see the Center for...

In current practice, gadolinium-based contrast agents have been considered safe when used at clinically recommended doses in patients without severe renal insufficiency.

Since its introduction more than 35 years ago, gadolinium-enhanced MRI has fundamentally changed medical practice. Although extraordinarily safe, gadolinium-based contrast agents …